Loading…

Polygenic Risk Scores in Alzheimer’s Disease Genetics: Methodology, Applications, Inclusion, and Diversity

The success of genome-wide association studies (GWAS) completed in the last 15 years has reinforced a key fact: polygenic architecture makes a substantial contribution to variation of susceptibility to complex disease, including Alzheimer’s disease. One straight-forward way to capture this architect...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Alzheimer's disease 2022-01, Vol.89 (1), p.1-12
Main Authors: Clark, Kaylyn, Leung, Yuk Yee, Lee, Wan-Ping, Voight, Benjamin, Wang, Li-San
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c383t-f97fd095a600062e01c076f2a028295600792445c4d29e3b0a89be56f6143e03
cites cdi_FETCH-LOGICAL-c383t-f97fd095a600062e01c076f2a028295600792445c4d29e3b0a89be56f6143e03
container_end_page 12
container_issue 1
container_start_page 1
container_title Journal of Alzheimer's disease
container_volume 89
creator Clark, Kaylyn
Leung, Yuk Yee
Lee, Wan-Ping
Voight, Benjamin
Wang, Li-San
description The success of genome-wide association studies (GWAS) completed in the last 15 years has reinforced a key fact: polygenic architecture makes a substantial contribution to variation of susceptibility to complex disease, including Alzheimer’s disease. One straight-forward way to capture this architecture and predict which individuals in a population are most at risk is to calculate a polygenic risk score (PRS). This score aggregates the risk conferred across multiple genetic variants, ultimately representing an individual’s predicted genetic susceptibility for a disease. PRS have received increasing attention after having been successfully used in complex traits. This has brought with it renewed attention on new methods which improve the accuracy of risk prediction. While these applications are initially informative, their utility is far from equitable: the majority of PRS models use samples heavily if not entirely of individuals of European descent. This basic approach opens concerns of health equity if applied inaccurately to other population groups, or health disparity if we fail to use them at all. In this review we will examine the methods of calculating PRS and some of their previous uses in disease prediction. We also advocate for, with supporting scientific evidence, inclusion of data from diverse populations in these existing and future studies of population risk via PRS.
doi_str_mv 10.3233/JAD-220025
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2691459788</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.3233_JAD-220025</sage_id><sourcerecordid>2707921194</sourcerecordid><originalsourceid>FETCH-LOGICAL-c383t-f97fd095a600062e01c076f2a028295600792445c4d29e3b0a89be56f6143e03</originalsourceid><addsrcrecordid>eNptkc9OFEEQxjsGI4hefADTCQeI2dH-MzPdzW2zCEIwGuU-6e2pWRp6p5euGZP1xGv4ejwJTRY0IZ6qUvnVV1_qI-QdZx-lkPLT2fSoEIIxUb0gO1yrqtCG6a3cS60KoZXaJq8Rrxhjkhn1imzLSpeacbNDwvcY1gvovaM_PF7Tny4mQOp7Og2_L8EvId3d_kF65BEsAj2BHgbv8JB-heEytjHExXpCp6tV8M4OPvY4oae9CyPmfkJt3-bdX5DQD-s35GVnA8Lbx7pLLo4_X8y-FOffTk5n0_PCSS2HojOqa5mpbJ0d1wIYd0zVnbBMaGGqPFVGlGXlylYYkHNmtZlDVXc1LyUwuUsONrKrFG9GwKFZenQQgu0hjtiI2vCyMkrrjO49Q6_imPpsrhHq4QznpszUhw3lUkRM0DWr5Jc2rRvOmocImhxBs4kgw-8fJcf5Etq_6NPPM7C_AdAu4N-9_0jdA1rcjC8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2707921194</pqid></control><display><type>article</type><title>Polygenic Risk Scores in Alzheimer’s Disease Genetics: Methodology, Applications, Inclusion, and Diversity</title><source>SAGE:Jisc Collections:SAGE Journals Read and Publish 2023-2024:2025 extension (reading list)</source><creator>Clark, Kaylyn ; Leung, Yuk Yee ; Lee, Wan-Ping ; Voight, Benjamin ; Wang, Li-San</creator><creatorcontrib>Clark, Kaylyn ; Leung, Yuk Yee ; Lee, Wan-Ping ; Voight, Benjamin ; Wang, Li-San</creatorcontrib><description>The success of genome-wide association studies (GWAS) completed in the last 15 years has reinforced a key fact: polygenic architecture makes a substantial contribution to variation of susceptibility to complex disease, including Alzheimer’s disease. One straight-forward way to capture this architecture and predict which individuals in a population are most at risk is to calculate a polygenic risk score (PRS). This score aggregates the risk conferred across multiple genetic variants, ultimately representing an individual’s predicted genetic susceptibility for a disease. PRS have received increasing attention after having been successfully used in complex traits. This has brought with it renewed attention on new methods which improve the accuracy of risk prediction. While these applications are initially informative, their utility is far from equitable: the majority of PRS models use samples heavily if not entirely of individuals of European descent. This basic approach opens concerns of health equity if applied inaccurately to other population groups, or health disparity if we fail to use them at all. In this review we will examine the methods of calculating PRS and some of their previous uses in disease prediction. We also advocate for, with supporting scientific evidence, inclusion of data from diverse populations in these existing and future studies of population risk via PRS.</description><identifier>ISSN: 1387-2877</identifier><identifier>EISSN: 1875-8908</identifier><identifier>DOI: 10.3233/JAD-220025</identifier><identifier>PMID: 35848019</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Alzheimer Disease - genetics ; Alzheimer's disease ; Genetic diversity ; Genetic Predisposition to Disease - genetics ; Genetic variance ; Genetics ; Genome-wide association studies ; Genome-Wide Association Study ; Genomes ; Humans ; Multifactorial Inheritance - genetics ; Neurodegenerative diseases ; Polygenic inheritance ; Population studies ; Risk ; Risk Factors</subject><ispartof>Journal of Alzheimer's disease, 2022-01, Vol.89 (1), p.1-12</ispartof><rights>2022 – The authors. Published by IOS Press</rights><rights>Copyright IOS Press BV 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c383t-f97fd095a600062e01c076f2a028295600792445c4d29e3b0a89be56f6143e03</citedby><cites>FETCH-LOGICAL-c383t-f97fd095a600062e01c076f2a028295600792445c4d29e3b0a89be56f6143e03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>313,314,776,780,788,27899,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35848019$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Clark, Kaylyn</creatorcontrib><creatorcontrib>Leung, Yuk Yee</creatorcontrib><creatorcontrib>Lee, Wan-Ping</creatorcontrib><creatorcontrib>Voight, Benjamin</creatorcontrib><creatorcontrib>Wang, Li-San</creatorcontrib><title>Polygenic Risk Scores in Alzheimer’s Disease Genetics: Methodology, Applications, Inclusion, and Diversity</title><title>Journal of Alzheimer's disease</title><addtitle>J Alzheimers Dis</addtitle><description>The success of genome-wide association studies (GWAS) completed in the last 15 years has reinforced a key fact: polygenic architecture makes a substantial contribution to variation of susceptibility to complex disease, including Alzheimer’s disease. One straight-forward way to capture this architecture and predict which individuals in a population are most at risk is to calculate a polygenic risk score (PRS). This score aggregates the risk conferred across multiple genetic variants, ultimately representing an individual’s predicted genetic susceptibility for a disease. PRS have received increasing attention after having been successfully used in complex traits. This has brought with it renewed attention on new methods which improve the accuracy of risk prediction. While these applications are initially informative, their utility is far from equitable: the majority of PRS models use samples heavily if not entirely of individuals of European descent. This basic approach opens concerns of health equity if applied inaccurately to other population groups, or health disparity if we fail to use them at all. In this review we will examine the methods of calculating PRS and some of their previous uses in disease prediction. We also advocate for, with supporting scientific evidence, inclusion of data from diverse populations in these existing and future studies of population risk via PRS.</description><subject>Alzheimer Disease - genetics</subject><subject>Alzheimer's disease</subject><subject>Genetic diversity</subject><subject>Genetic Predisposition to Disease - genetics</subject><subject>Genetic variance</subject><subject>Genetics</subject><subject>Genome-wide association studies</subject><subject>Genome-Wide Association Study</subject><subject>Genomes</subject><subject>Humans</subject><subject>Multifactorial Inheritance - genetics</subject><subject>Neurodegenerative diseases</subject><subject>Polygenic inheritance</subject><subject>Population studies</subject><subject>Risk</subject><subject>Risk Factors</subject><issn>1387-2877</issn><issn>1875-8908</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>AFRWT</sourceid><recordid>eNptkc9OFEEQxjsGI4hefADTCQeI2dH-MzPdzW2zCEIwGuU-6e2pWRp6p5euGZP1xGv4ejwJTRY0IZ6qUvnVV1_qI-QdZx-lkPLT2fSoEIIxUb0gO1yrqtCG6a3cS60KoZXaJq8Rrxhjkhn1imzLSpeacbNDwvcY1gvovaM_PF7Tny4mQOp7Og2_L8EvId3d_kF65BEsAj2BHgbv8JB-heEytjHExXpCp6tV8M4OPvY4oae9CyPmfkJt3-bdX5DQD-s35GVnA8Lbx7pLLo4_X8y-FOffTk5n0_PCSS2HojOqa5mpbJ0d1wIYd0zVnbBMaGGqPFVGlGXlylYYkHNmtZlDVXc1LyUwuUsONrKrFG9GwKFZenQQgu0hjtiI2vCyMkrrjO49Q6_imPpsrhHq4QznpszUhw3lUkRM0DWr5Jc2rRvOmocImhxBs4kgw-8fJcf5Etq_6NPPM7C_AdAu4N-9_0jdA1rcjC8</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Clark, Kaylyn</creator><creator>Leung, Yuk Yee</creator><creator>Lee, Wan-Ping</creator><creator>Voight, Benjamin</creator><creator>Wang, Li-San</creator><general>SAGE Publications</general><general>IOS Press BV</general><scope>AFRWT</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20220101</creationdate><title>Polygenic Risk Scores in Alzheimer’s Disease Genetics: Methodology, Applications, Inclusion, and Diversity</title><author>Clark, Kaylyn ; Leung, Yuk Yee ; Lee, Wan-Ping ; Voight, Benjamin ; Wang, Li-San</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c383t-f97fd095a600062e01c076f2a028295600792445c4d29e3b0a89be56f6143e03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Alzheimer Disease - genetics</topic><topic>Alzheimer's disease</topic><topic>Genetic diversity</topic><topic>Genetic Predisposition to Disease - genetics</topic><topic>Genetic variance</topic><topic>Genetics</topic><topic>Genome-wide association studies</topic><topic>Genome-Wide Association Study</topic><topic>Genomes</topic><topic>Humans</topic><topic>Multifactorial Inheritance - genetics</topic><topic>Neurodegenerative diseases</topic><topic>Polygenic inheritance</topic><topic>Population studies</topic><topic>Risk</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Clark, Kaylyn</creatorcontrib><creatorcontrib>Leung, Yuk Yee</creatorcontrib><creatorcontrib>Lee, Wan-Ping</creatorcontrib><creatorcontrib>Voight, Benjamin</creatorcontrib><creatorcontrib>Wang, Li-San</creatorcontrib><collection>SAGE Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of Alzheimer's disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Clark, Kaylyn</au><au>Leung, Yuk Yee</au><au>Lee, Wan-Ping</au><au>Voight, Benjamin</au><au>Wang, Li-San</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Polygenic Risk Scores in Alzheimer’s Disease Genetics: Methodology, Applications, Inclusion, and Diversity</atitle><jtitle>Journal of Alzheimer's disease</jtitle><addtitle>J Alzheimers Dis</addtitle><date>2022-01-01</date><risdate>2022</risdate><volume>89</volume><issue>1</issue><spage>1</spage><epage>12</epage><pages>1-12</pages><issn>1387-2877</issn><eissn>1875-8908</eissn><abstract>The success of genome-wide association studies (GWAS) completed in the last 15 years has reinforced a key fact: polygenic architecture makes a substantial contribution to variation of susceptibility to complex disease, including Alzheimer’s disease. One straight-forward way to capture this architecture and predict which individuals in a population are most at risk is to calculate a polygenic risk score (PRS). This score aggregates the risk conferred across multiple genetic variants, ultimately representing an individual’s predicted genetic susceptibility for a disease. PRS have received increasing attention after having been successfully used in complex traits. This has brought with it renewed attention on new methods which improve the accuracy of risk prediction. While these applications are initially informative, their utility is far from equitable: the majority of PRS models use samples heavily if not entirely of individuals of European descent. This basic approach opens concerns of health equity if applied inaccurately to other population groups, or health disparity if we fail to use them at all. In this review we will examine the methods of calculating PRS and some of their previous uses in disease prediction. We also advocate for, with supporting scientific evidence, inclusion of data from diverse populations in these existing and future studies of population risk via PRS.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>35848019</pmid><doi>10.3233/JAD-220025</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1387-2877
ispartof Journal of Alzheimer's disease, 2022-01, Vol.89 (1), p.1-12
issn 1387-2877
1875-8908
language eng
recordid cdi_proquest_miscellaneous_2691459788
source SAGE:Jisc Collections:SAGE Journals Read and Publish 2023-2024:2025 extension (reading list)
subjects Alzheimer Disease - genetics
Alzheimer's disease
Genetic diversity
Genetic Predisposition to Disease - genetics
Genetic variance
Genetics
Genome-wide association studies
Genome-Wide Association Study
Genomes
Humans
Multifactorial Inheritance - genetics
Neurodegenerative diseases
Polygenic inheritance
Population studies
Risk
Risk Factors
title Polygenic Risk Scores in Alzheimer’s Disease Genetics: Methodology, Applications, Inclusion, and Diversity
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T23%3A50%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Polygenic%20Risk%20Scores%20in%20Alzheimer%E2%80%99s%20Disease%20Genetics:%20Methodology,%20Applications,%20Inclusion,%20and%20Diversity&rft.jtitle=Journal%20of%20Alzheimer's%20disease&rft.au=Clark,%20Kaylyn&rft.date=2022-01-01&rft.volume=89&rft.issue=1&rft.spage=1&rft.epage=12&rft.pages=1-12&rft.issn=1387-2877&rft.eissn=1875-8908&rft_id=info:doi/10.3233/JAD-220025&rft_dat=%3Cproquest_cross%3E2707921194%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c383t-f97fd095a600062e01c076f2a028295600792445c4d29e3b0a89be56f6143e03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2707921194&rft_id=info:pmid/35848019&rft_sage_id=10.3233_JAD-220025&rfr_iscdi=true